Cargando…

Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial

BACKGROUND: Evidence for the prognostic implications of hyperglycaemia in older adults is inconsistent. OBJECTIVE: To evaluate disability-free survival (DFS) in older individuals by glycaemic status. METHODS: This analysis used data from a randomised trial recruiting 19,114 community-based participa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhen, Curtis, Andrea J, Owen, Alice, Wolfe, Rory, Murray, Anne M, Tonkin, Andrew M, Ernst, Michael E, Orchard, Suzanne G, Zhu, Chao, Carr, Prudence R, Reid, Christopher M, Espinoza, Sara E, Shah, Raj C, Woods, Robyn L, Ryan, Joanne, McNeil, John J, Nelson, Mark R, Zoungas, Sophia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128162/
https://www.ncbi.nlm.nih.gov/pubmed/37097768
http://dx.doi.org/10.1093/ageing/afad060
_version_ 1785030551692902400
author Zhou, Zhen
Curtis, Andrea J
Owen, Alice
Wolfe, Rory
Murray, Anne M
Tonkin, Andrew M
Ernst, Michael E
Orchard, Suzanne G
Zhu, Chao
Carr, Prudence R
Reid, Christopher M
Espinoza, Sara E
Shah, Raj C
Woods, Robyn L
Ryan, Joanne
McNeil, John J
Nelson, Mark R
Zoungas, Sophia
author_facet Zhou, Zhen
Curtis, Andrea J
Owen, Alice
Wolfe, Rory
Murray, Anne M
Tonkin, Andrew M
Ernst, Michael E
Orchard, Suzanne G
Zhu, Chao
Carr, Prudence R
Reid, Christopher M
Espinoza, Sara E
Shah, Raj C
Woods, Robyn L
Ryan, Joanne
McNeil, John J
Nelson, Mark R
Zoungas, Sophia
author_sort Zhou, Zhen
collection PubMed
description BACKGROUND: Evidence for the prognostic implications of hyperglycaemia in older adults is inconsistent. OBJECTIVE: To evaluate disability-free survival (DFS) in older individuals by glycaemic status. METHODS: This analysis used data from a randomised trial recruiting 19,114 community-based participants aged ≥70 years, who had no prior cardiovascular events, dementia and physical disability. Participants with sufficient information to ascertain their baseline diabetes status were categorised as having normoglycaemia (fasting plasma glucose [FPG] < 5.6 mmol/l, 64%), prediabetes (FPG 5.6 to <7.0 mmol/l, 26%) and diabetes (self-report or FPG ≥ 7.0 mmol/l or use of glucose-lowering agents, 11%). The primary outcome was loss of disability-free survival (DFS), a composite of all-cause mortality, persistent physical disability or dementia. Other outcomes included the three individual components of the DFS loss, as well as cognitive impairment-no dementia (CIND), major adverse cardiovascular events (MACE) and any cardiovascular event. Cox models were used for outcome analyses, with covariate adjustment using inverse-probability weighting. RESULTS: We included 18,816 participants (median follow-up: 6.9 years). Compared to normoglycaemia, participants with diabetes had greater risks of DFS loss (weighted HR: 1.39, 95% CI 1.21–1.60), all-cause mortality (1.45, 1.23–1.72), persistent physical disability (1.73, 1.35–2.22), CIND (1.22, 1.08–1.38), MACE (1.30, 1.04–1.63) and cardiovascular events (1.25, 1.02–1.54) but not dementia (1.13, 0.87–1.47). The prediabetes group did not have an excess risk for DFS loss (1.02, 0.93–1.12) or other outcomes. CONCLUSIONS: Among older people, diabetes was associated with reduced DFS, and higher risk of CIND and cardiovascular outcomes, whereas prediabetes was not. The impact of preventing or treating diabetes in this age group deserves closer attention.
format Online
Article
Text
id pubmed-10128162
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101281622023-04-26 Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial Zhou, Zhen Curtis, Andrea J Owen, Alice Wolfe, Rory Murray, Anne M Tonkin, Andrew M Ernst, Michael E Orchard, Suzanne G Zhu, Chao Carr, Prudence R Reid, Christopher M Espinoza, Sara E Shah, Raj C Woods, Robyn L Ryan, Joanne McNeil, John J Nelson, Mark R Zoungas, Sophia Age Ageing Research Paper BACKGROUND: Evidence for the prognostic implications of hyperglycaemia in older adults is inconsistent. OBJECTIVE: To evaluate disability-free survival (DFS) in older individuals by glycaemic status. METHODS: This analysis used data from a randomised trial recruiting 19,114 community-based participants aged ≥70 years, who had no prior cardiovascular events, dementia and physical disability. Participants with sufficient information to ascertain their baseline diabetes status were categorised as having normoglycaemia (fasting plasma glucose [FPG] < 5.6 mmol/l, 64%), prediabetes (FPG 5.6 to <7.0 mmol/l, 26%) and diabetes (self-report or FPG ≥ 7.0 mmol/l or use of glucose-lowering agents, 11%). The primary outcome was loss of disability-free survival (DFS), a composite of all-cause mortality, persistent physical disability or dementia. Other outcomes included the three individual components of the DFS loss, as well as cognitive impairment-no dementia (CIND), major adverse cardiovascular events (MACE) and any cardiovascular event. Cox models were used for outcome analyses, with covariate adjustment using inverse-probability weighting. RESULTS: We included 18,816 participants (median follow-up: 6.9 years). Compared to normoglycaemia, participants with diabetes had greater risks of DFS loss (weighted HR: 1.39, 95% CI 1.21–1.60), all-cause mortality (1.45, 1.23–1.72), persistent physical disability (1.73, 1.35–2.22), CIND (1.22, 1.08–1.38), MACE (1.30, 1.04–1.63) and cardiovascular events (1.25, 1.02–1.54) but not dementia (1.13, 0.87–1.47). The prediabetes group did not have an excess risk for DFS loss (1.02, 0.93–1.12) or other outcomes. CONCLUSIONS: Among older people, diabetes was associated with reduced DFS, and higher risk of CIND and cardiovascular outcomes, whereas prediabetes was not. The impact of preventing or treating diabetes in this age group deserves closer attention. Oxford University Press 2023-04-23 /pmc/articles/PMC10128162/ /pubmed/37097768 http://dx.doi.org/10.1093/ageing/afad060 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Research Paper
Zhou, Zhen
Curtis, Andrea J
Owen, Alice
Wolfe, Rory
Murray, Anne M
Tonkin, Andrew M
Ernst, Michael E
Orchard, Suzanne G
Zhu, Chao
Carr, Prudence R
Reid, Christopher M
Espinoza, Sara E
Shah, Raj C
Woods, Robyn L
Ryan, Joanne
McNeil, John J
Nelson, Mark R
Zoungas, Sophia
Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial
title Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial
title_full Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial
title_fullStr Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial
title_full_unstemmed Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial
title_short Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial
title_sort prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the aspirin in reducing events in the elderly trial
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128162/
https://www.ncbi.nlm.nih.gov/pubmed/37097768
http://dx.doi.org/10.1093/ageing/afad060
work_keys_str_mv AT zhouzhen prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT curtisandreaj prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT owenalice prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT wolferory prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT murrayannem prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT tonkinandrewm prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT ernstmichaele prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT orchardsuzanneg prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT zhuchao prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT carrprudencer prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT reidchristopherm prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT espinozasarae prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT shahrajc prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT woodsrobynl prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT ryanjoanne prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT mcneiljohnj prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT nelsonmarkr prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial
AT zoungassophia prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial